Developing normalized strength scores for neuromuscular research

被引:11
作者
Andres, Patricia L. [1 ]
English, Robert [2 ]
Mendoza, Michelle [3 ]
Florence, Julaine [4 ]
Malkus, Elizabeth [4 ]
Schierbecker, Jeanine [4 ]
Siener, Catherine [4 ]
Malspeis, Susan [5 ]
Schoenfeld, David A. [5 ]
Munsat, Theodore L. [6 ]
Cudkowicz, Merit E. [1 ]
机构
[1] Massachusetts Gen Hosp, Neurol Clin Trials Unit, Charlestown, MA 02129 USA
[2] Univ Kentucky, Dept Phys Therapy, Lexington, KY USA
[3] Calif Pacific Med Ctr, Forbes Norris MDA ALS Res Ctr, San Francisco, CA USA
[4] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[5] Massachusetts Gen Hosp, Biostat Ctr, Charlestown, MA 02129 USA
[6] Tufts Med Ctr, Dept Neurol, Boston, MA USA
关键词
ALS; neuromuscular; outcomes measures; strength testing; summary scores; VOLUNTARY ISOMETRIC CONTRACTION; AMYOTROPHIC-LATERAL-SCLEROSIS; CLINICAL-TRIALS; ALS;
D O I
10.1002/mus.23516
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Introduction: The Accurate Test of Limb Isometric Strength (ATLIS) device can reliably measure the strength of 12 muscle groups using a fixed load cell. The purpose of this study was to analyze ATLIS data from healthy adults to calculate an individual's predicted strength scores. Methods: ATLIS data were collected from 432 healthy adults. Linear regression models were developed to predict each muscle group's strength. The R-squared statistic assessed variability accounted for by the models. Results: Simple main effects models stratified by gender were used to establish regression equations for each muscle using factors of age, weight, and height. Conclusions: Normalizing raw strength scores controls for biometric factors, thus enabling meaningful comparisons between subjects and allowing each muscle to contribute equally to a summary score. Normalized scores are easily interpreted for broad clinical uses, and derived summary scores establish individuals' disease progression rates using a common scale, allowing for more efficient clinical trials. Muscle Nerve 47: 177-182, 2013
引用
收藏
页码:177 / 182
页数:6
相关论文
共 34 条
[1]
Ciliary neurotrophic factor genotype does not influence clinical phenotype in amyotrophic lateral sclerosis [J].
Al-Chalabi, A ;
Scheffler, MD ;
Smith, BN ;
Parton, MJ ;
Cudkowicz, ME ;
Andersen, PM ;
Hayden, DL ;
Hansen, VK ;
Turner, MR ;
Shaw, CE ;
Leigh, PN ;
Brown, RH .
ANNALS OF NEUROLOGY, 2003, 54 (01) :130-134
[2]
Andres P., 2005, AMYOTROPH LATERAL S, V6, P134
[3]
Validation of a new strength measurement device for amyotrophic lateral sclerosis clinical trials [J].
Andres, Patricia L. ;
Skerry, Linda M. ;
Munsat, Theodore L. ;
Thornell, Brenda J. ;
Szymonifka, Jackie ;
Schoenfeld, David A. ;
Cudkowicz, Merit E. .
MUSCLE & NERVE, 2012, 45 (01) :81-85
[4]
A comparison of three measures of disease progression in ALS [J].
Andres, PL ;
Skerry, LM ;
Thornell, B ;
Portney, LG ;
Finison, LJ ;
Munsat, TL .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 139 :64-70
[5]
QUANTITATIVE MOTOR-ASSESSMENT IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].
ANDRES, PL ;
HEDLUND, W ;
FINISON, L ;
CONLON, T ;
FELMUS, M ;
MUNSAT, TL .
NEUROLOGY, 1986, 36 (07) :937-941
[6]
USE OF COMPOSITE SCORES (MEGASCORES) TO MEASURE DEFICIT IN AMYOTROPHIC LATERAL SCLEROSIS [J].
ANDRES, PL ;
FINISON, LJ ;
CONLON, T ;
THIBODEAU, LM ;
MUNSAT, TL .
NEUROLOGY, 1988, 38 (03) :405-408
[7]
[Anonymous], AIDS INV PER NERV IN
[8]
Comparing composite scores based on maximal voluntary isometric contraction and oil semiquantitative manual motor testing in measuring limb strength in patients with ALS [J].
Armon, C ;
Ponraj, E .
NEUROLOGY, 1996, 47 (06) :1586-1587
[9]
Beck M, 1999, MUSCLE NERVE, V22, P1265, DOI 10.1002/(SICI)1097-4598(199909)22:9<1265::AID-MUS15>3.3.CO
[10]
2-6